Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction

Journal of Cranio-Maxillofacial Surgery

Volumn 43, Issue 4, 2015, Pages 510-514

  Bodem, Jens Philipp ^a   Kargus, Steffen ^a   Eckstein, Stefanie ^a   Saure, Daniel ^b   Engel, Michael ^a   Hoffmann, Jürgen ^a   Freudlsperger, Christian ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antibiotic prophylaxis; Bisphosphonate related osteonecrosis of the jaw; BRONJ; Osteotomy; Tooth extraction

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; IBANDRONIC ACID; MOUTHWASH; PAMIDRONIC ACID; PENICILLIN DERIVATIVE; SULTAMICILLIN; ZOLEDRONIC ACID; TOPICAL ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BREAST CANCER; FEEDING APPARATUS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; JAW OSTEONECROSIS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MANDIBLE RESECTION; MULTIPLE MYELOMA; OSTEOTOMY; PROSTATE CANCER; RECTUM CARCINOMA; TOOTH; TOOTH EXTRACTION; TRANSITIONAL CELL CARCINOMA; ADULT; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPARATIVE STUDY; DIGESTIVE TRACT INTUBATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEOPLASMS; PREOPERATIVE CARE; PROCEDURES; RISK FACTOR; SURGERY; SURGICAL FLAPS; TIME FACTOR; TOOTH SOCKET; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CHLORHEXIDINE; CLINICAL PROTOCOLS; COHORT STUDIES; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; MOUTHWASHES; NEOPLASMS; OSTEOTOMY; PREOPERATIVE CARE; RISK FACTORS; SURGICAL FLAPS; TIME FACTORS; TOOTH EXTRACTION; TOOTH SOCKET;

EID: 84929131164     PISSN: 10105182     EISSN: 18784119     Source Type: Journal    
DOI: 10.1016/j.jcms.2015.02.018     Document Type: Article

References (24)

1. J.R. Berenson, L. Rajdev, and M. Broder Treatment strategies for skeletal complications of cancer Cancer Biol Ther 5 2006 1074 1077
2. J.P. Bilezikian Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis Am J Med 122 2009 S14 S21
3. J.J. Body Breast cancer: bisphosphonate therapy for metastatic bone disease Clin Cancer Res 12 2006 6258s 6263s
4. J.J. Body, R. Coleman, P. Clezardin, C. Ripamonti, R. Rizzoli, and M. Aapro et al. International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients Eur J Cancer 43 2007 852 858
5. J. Cornish, U. Bava, K.E. Callon, J. Bai, D. Naot, and I.R. Reid Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells Bone 49 2011 710 716
6. F. Cosman Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates Endocr Pract 15 2009 483 493
7. O. Filleul, E. Crompot, and S. Saussez Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases J Cancer Res Clin Oncol 136 2010 1117 1124
8. T. Hasegawa, S. Ri, M. Umeda, H. Komatsubara, M. Kobayashi, and T. Shigeta et al. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy J Cranio-Maxillofacial Surg 41 2013 558 563
9. A.O. Hoff, B.B. Toth, K. Altundag, M.M. Johnson, C.L. Warneke, and M. Hu et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826 836
10. S. Khosla, D. Burr, J. Cauley, D.W. Dempster, P.R. Ebeling, and D. Felsenberg et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479 1491
11. G. Lodi, A. Sardella, A. Salis, F. Demarosi, M. Tarozzi, and A. Carrassi Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series J Oral Maxillofac Surg 68 2010 107 110
12. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
13. S. Otto, C. Schreyer, S. Hafner, G. Mast, M. Ehrenfeld, and S. Stürzenbaum et al. Bisphosphonate-related osteonecrosis of the jaws - Characteristics, risk factors, clinical features, localization and impact on oncological treatment J Cranio-Maxillofacial Surg 40 2012 303 309
14. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update J Oral Maxillofac Surg 67 2009 2 12
15. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, B. Mehrotra Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws AeAoOaMS American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update Aust Endod J 35 2009 119 130
16. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
17. R.G. Russell, Z. Xia, J.E. Dunford, U. Oppermann, A. Kwaasi, and P.A. Hulley et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy Ann N Y Acad Sci 1117 2007 209 257
18. G. Saia, S. Blandamura, G. Bettini, A. Tronchet, A. Totola, and G. Bedogni et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction J Oral Maxillofac Surg 68 2010 797 804
19. M. Scoletta, V. Arata, P.G. Arduino, E. Lerda, A. Chiecchio, and G. Gallesio et al. Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol J Oral Maxillofac Surg 71 2013 994 999
20. M. Scoletta, P.G. Arduino, R. Pol, V. Arata, S. Silvestri, and A. Chiecchio et al. Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report J Oral Maxillofac Surg 69 2011 456 462
21. V. Vassiliou, N. Tselis, and D. Kardamakis Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies Strahlenther Onkol 186 2010 367 373
22. P. Vescovi, G. Campisi, V. Fusco, G. Mergoni, M. Manfredi, and E. Merigo et al. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study Oral Oncol 47 2011 191 194
23. P.J. Voss, J. Joshi Oshero, A. Kovalova-Müller, E.A. Veigel Merino, S. Sauerbier, and J. Al-Jamali et al. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients J Cranio-Maxillofacial Surg 40 2012 719 725
24. C. Walter, B. Al-Nawas, A. du Bois, L. Buch, P. Harter, and K.A. Grötz Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients Cancer 115 2009 1631 1637